Pier 88 Investment Partners LLC Krystal Biotech, Inc. Transaction History
Pier 88 Investment Partners LLC
- $75.6 Million
- Q4 2024
A detailed history of Pier 88 Investment Partners LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 3,750 shares of KRYS stock, worth $584,062. This represents 0.78% of its overall portfolio holdings.
Number of Shares
3,750
Previous 3,530
6.23%
Holding current value
$584,062
Previous $641,000
8.42%
% of portfolio
0.78%
Previous 0.84%
Shares
4 transactions
Others Institutions Holding KRYS
# of Institutions
308Shares Held
24.5MCall Options Held
506KPut Options Held
383K-
Black Rock Inc. New York, NY3.95MShares$615 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$448 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.62MShares$408 Million7.18% of portfolio
-
State Street Corp Boston, MA1.45MShares$226 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$154 Million9.67% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...